ISTANBUL, Nov. 8, 2024 /PRNewswire/ -- At the Global Mobile Broadband Forum 2024 (MBBF 2024), Cao Ming, Vice President of Huawei and President of Huawei's Wireless Solution, launched 5G-AA solutions. Cao said: "Mobile AI is changing our lives. The arising new connections and services pose increasingly higher requirements on networks. Huawei's 5G-AA 10 solutions build multidimensional ultimate network capabilities through the full-series Advanced Radio, enable full-domain site digitalization through Ambient Site, and achieve L4 network autonomy through the Agent-based digital engineers team. With such excellent performance, these solutions will help operators meet the ever-diversifying demand for services in the Mobile AI era."
Huawei's 5G-AA solutions will deepen the convergence of 5.5G and AI through 'Networks for AI' and 'AI for Networks'. 'Networks for AI' will enable networks to possess the sufficient capabilities that are required to address differentiated service requirements and improve both network performance and user experiences. 'AI for Networks' will equip networks with L4 autonomy through digital sites and RAN Agents. Operators can use these solutions in a wide range of scenarios to sustain their leading positions.
1. Sub-1 GHz Massive MIMO builds a ubiquitous foundation layer for Mobile AI. Sub-1 GHz Massive MIMO provides an innovative solution to many technical challenges to meet the general deployment requirements of site engineering, bringing Massive MIMO to low bands. While providing extensive coverage, low-band Massive MIMO improves downlink, uplink, and low-latency experiences. It supports full access from all RATs, full IoT connectivity, and full real-time service guarantee.
2. Unique sub-6 GHz all-band integration in one box enables simplified single-antenna Massive MIMO deployment. Blade AAU X is the industry's first product that uses a single antenna to support Massive MIMO deployment across all sub-6 GHz bands. Unlike other Massive MIMO modules, this product can be deployed on a single pole, and requires 50% less site space and 70% lower OPEX. It supports GHz-level bandwidth with one pole, maximizing spectral efficiency.
3. The industry's first unique U6GHz AAU ensures continuous 10 Gbps. The U6GHz AAU integrates more than 1,500 antenna elements and uses leading MU-MIMO algorithms. With the collaboration of such leading hardware and software, it supports a capacity of up to 100 Gbps and speeds of up to 10 Gbps. It enables coverage to be aligned with C-band to ensure uninterrupted Gbps experiences indoors.
4. LampSite introduces Passive IoT (P-IoT) for the first time to upgrade digital intelligence indoors. LampSite X supports both indoor 10 Gbps and P-IoT access. It can be deployed in half the time and allows asset stocktaking to be done daily, instead of monthly, compared with other solutions.
5. The industry's lightest AAU enables simplified mid-band deployment with a huge bandwidth. EasyAAU is the industry's lightest AAU product, weighing half of an 8T RRU model. This enables it to be deployed on walls in urban areas and poles in rural areas to quickly provide 5G coverage. The delivery time is 40% shorter and the capacity can also be doubled.
6. The industry's first microwave-antenna integration overcomes antenna installation challenges. Integrated antenna and microwave (IAM) houses antennas and E-band microwave units in one box, which reduces single-box weight by 30% and the space needed for installation by 50%. The antenna also supports all-beam auto-seeking, which helps reduce maintenance costs.
7. The industry's first full-duplex microwave upgrades transmission capacity. The industry's first full-duplex microwave, MAGICSwave, uses super-isolated antennas and interference cancellation algorithms to double spectral efficiency. It has a capacity of up to 50 Gbps, allowing operators to navigate the huge demand for data transmission in the Mobile AI era.
8. The industry's first one-box rural network solution helps narrow down the connection gap in rural areas. RuralCOW represents an upgrade from RuralStar and RuralLink. By integrating fronthaul units and radio units into one box, it can be deployed without needing backhaul, BBU, and main power supplies. This significantly reduces the site costs of multi-RAT deployments in remote areas and suburbs.
9. Agent-based digital engineers team enables higher-level network autonomy. Based on the intelligent RAN Agent, the Agent-based digital engineers team has been incubated, which includes four digital experts that perform unattended maintenance, real-time network optimization, 24/7 energy saving, and accurate service provisioning evaluation.
10. Unique full-domain digital sites enable visualized site-level sensing and control. Ambient Site links a site's main equipment with its antennas, power supplies, and transmission devices, helping realize full site digitalization. This enables networks to improve energy saving and user experiences.
"Mobile AI is on the horizon. We will continue to work with all industry partners and innovate to promote the integration of 5.5G and AI," concluded Cao.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Huawei Launches the Latest 5G-A Solutions for the Mobile AI Era
SHANGHAI and SAN DIEGO, Nov. 8, 2024 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates (XDCs), is proud to announce that it has been named the winner of the "Best CDMO" at the World ADC Awards 2024 for the second consecutive year. Over the past three years, WuXi XDC has consistently earned recognition at the World ADC Awards, including being named the winner of the"Best CDMO" in 2023 and "Best CMO Runner-up" in 2022. This year, the company is also shortlisted for "Best ADC Platform Technology" and "Best CRO", highlighting its strong R&D capability and contributions to ADC development.
The prestigious award, presented at the World ADC San Diego conference, recognizes WuXi XDC's end-to-end, one-stop CRDMO excellence and exceptional services to global clients. The company's record of consecutive awards highlights its expertise and technical strength in driving innovation in the global ADC industry and meeting the complex needs from clients worldwide.
The World ADC Awards are held annually to recognize the outstanding achievements by teams, projects, technologies and individuals in the global ADC industry. The World ADC is a flagship event that brings together the brightest minds in ADC development, featuring key industry experts, breakthrough technologies, and forward-thinking collaborations. The 2024 conference in San Diego highlighted the latest advancements in ADCs and XDCs, from research through to commercialization, and celebrated innovations in the bioconjugate space.
Dr. Jimmy Li, CEO of WuXi XDC stated: "Winning the prestigious award at the World ADC is a tremendous honor for WuXi XDC and a reflection of our team's relentless dedication to innovation and excellence. The recognition underscores the significant trust our clients place in us. Receiving the winner of the 'Best CDMO' award for two consecutive years highlights the consistency of our efforts and our position as a global leader in the ADC industry. WuXi XDC's mission is to accelerate and transform the discovery, development and manufacturing of bioconjugates through a comprehensive open-access platform, enabling our global healthcare partners and benefiting patients worldwide. We will strive to provide our clients with state-of-the-art technologies and integrated solutions to contribute to the global healthcare industry."
WuXi XDC won the Best CDMO Winner award for its integrated, one-stop CRDMO platform. The platform provides comprehensive, end-to-end services that significantly reduce timelines and mitigate risks associated with ADC development and manufacturing. With WuXi XDC's integrated solutions, the DNA-to-IND timeline for ADCs has been shortened to 15 months or less, significantly cutting down the conventional timeline to enter clinical trials by almost half. Additionally, WuXi XDC accelerates the development to Biologics License Application (BLA) within 24-36 months.
WuXi XDC's success is attributed to profound expertise in ADC technology, extensive experience in handling complex bioconjugates, and a truly integrated approach that unifies discovery, development, and manufacturing. By leveraging cutting-edge technologies and a global team of industry experts, WuXi XDC ensures seamless interdisciplinary collaboration, thereby minimizing risks and maximizing efficiency throughout the ADC development process.
The all-in-one manufacturing strategy integrates all four key phases of ADC production – mAb intermediate, linker-payload, drug substance, drug product – into one single site, ensuring seamless coordination and highest product quality. This approach makes WuXi XDC a reliable partner for clients seeking to advance their ADC/XDC programs efficiently and effectively. This combination of cutting-edge technology, industry experience and integrated solutions is what distinguishes WuXi XDC as a leader in the evolving ADC landscape.
As highlighted in the 2024 interim report, WuXi XDC's leadership in the ADC field is demonstrated by its expanding client base, growing to encompass 419 clients globally. Notably, 13 of the top 20 global pharmaceutical companies (ranked by 2023 revenue) have chosen WuXi XDC as their trusted partner, reflecting the high level of confidence placed in the company's expertise and capabilities.
The recognition from the World ADC Awards underscores WuXi XDC's relentless pursuit of excellence in delivering comprehensive service solutions to global clients. As a leading CRDMO in ADC and bioconjugates, WuXi XDC strives to remain at the forefront of innovation, empowering clients worldwide to accelerate the development of transformative therapies and benefit patients worldwide.
About WuXi XDC
WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK) is a leading global CRDMO focused on antibody drug conjugates (ADC) and the broader bioconjugate market. It provides end-to-end contract research, development and manufacturing services for bioconjugates, including ADCs. Its services cover antibody intermediates and other biologics intermediates, chemical payloads and linkers, as well as bioconjugate drug substances and drug products. For more information about WuXi XDC, please visit: www.wuxixdc.com.
WuXi XDC Contacts
Investor：wuxixdc.ir@wuxibiologics.com
Media：wuxixdc_pr@wuxibiologics.com
BD：wuxixdc_info@wuxibiologics.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards
